A detailed history of Wellington Management Group LLP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 107,820 shares of BCRX stock, worth $757,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,820
Holding current value
$757,974
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.41 - $8.69 $691,126 - $936,955
107,820 New
107,820 $819,000
Q1 2020

May 14, 2020

SELL
$1.6 - $4.11 $36,332 - $93,329
-22,708 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$1.59 - $3.45 $36,105 - $78,342
22,708 New
22,708 $78,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.31B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.